Neurology and CNS Clinical Development

Driving successful outcomes for CNS and Neurology trials is challenging

Second, only to Oncology, CNS and Neurology clinical trials are incredibly complex and complicated to navigate. CNS trials are plagued with high failure rates at or before phase III, and therefore require careful risk mitigation throughout trial design and execution with close regulatory agency collaboration.

That is why Veristat has built a team of scientific-minded experts who have supported more than 150 CNS/Neurology projects, including drug, biologic, and diagnostic trials. More than 40% of these treatments are for rare neurological diseases or disorders. 

Driving CNS and Neurology Treatments to Approval

Our diverse trial experience, coupled with our knowledgeable and experienced teams, allows us to confidently handle the most complex trials and patient populations with the attention and focus needed to navigate the neurological disease landscape.

At Veristat, our experienced teams are poised to plan and implement these efforts quickly providing:     


> 150

projects supported for CNS/Neurology Disorders



clinical trials are rare disorders

Veristat_icon_gene therapy

> 25%

clinical trials are genetic neurological disorders

Explore Our Recent Neurology Experience

Neurology Indications
   Adrenoleukodystrophy    Epilepsy    Pain & Inflammation
   Alzheimer's Disease    Friedreich's Ataxia    Parkinson's Disease
   Amyotrophic lateral sclerosis (ALS)     Genetic Abnormalities    Pompe Disease
   Attention Deficit Disorder (ADD)    Hearing Loss    Post-Operative Pain
   Attention Deficit/Hyperactivity Disorder (ADHD)     Insomnia     Sanfilippo Syndrome
   Autism Spectrum Disorder    Limb Girdle Muscular Dystrophy Type 2i (LGMD2i)    Schizophrenia
   Canavan Disease     Lumbar Radiculopathy     Sjogren-Larsson Syndrome (SLS)
   Cerebral Adrenoleukodystrophy (CALD)    Maroteaux-Lamy Syndrome     Sleep Apnea/ Sleep Dysfunction
   Depression     Migraine     Stroke 
   Diabetic Neuropathy Pain     Multiple Sclerosis (MS)     Spasticity Due to Spinal Cord Injury 
   Dravet Syndrome     Nocturnal Foot and/or leg cramps    Spinocerebellar Ataxia (SCA)
   Duchenne Muscular Dystrophy     Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)     Tardive Dyskinesia


Learn More with These Resources


Marketing Applications Approval Record

Veristat is proud to have supported the preparation of 75 marketing applications (NDA, BLA, MAA, etc) that are now approved for patients. For these approved products, direct ...


Case Study

Preparing Data for the Marketing Authorization Application ...

Read the case study to learn how we helped a biotech prepare the MAA submission for a recently acquired product. Our creative approach included utilizing one DB for three ...


Conference Presentation

Turning Sponsor/CRO Relationships into Partnerships for ...

Get the presentation that was given at the Evolution Summit Fall 2019. Veristat and thier client Ascendis Pharma share thier thoughts on how to truly work as a partnership to ...

Request A Proposal